US OptionsDetailed Quotes

IRON240816P40000

Watchlist

1.40
+0.40+40.00%

15min DelayTrading Jul 22 11:37 ET

1.40High1.40Low

Disc Medicine Stock Discussion

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

7122413

Apr 1 12:52

$Disc Medicine(IRON.US)$ easy money

Invest with Sarge

Apr 1 11:15

Not Ironman ...

Disc Medicine $Disc Medicine(IRON.US)$ down 55% on Monday.

Meltyy

Jan 3 06:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

Analysts Notebook

Dec 27, 2023 04:18

ColumnsBiotech Outlook 2024: Analysts Believe the Biotech Sector is Poised for Recovery Next Year

Following a turbulent period, there has been a notable change in the trajectory of biotech stocks. After experiencing significant downturns in 2021 and 2022, the $SPDR S&P Biotech ETF(XBI.US)$ has seen an increase of 5.5% in the current year. However, it continues to trail considerably behind the $S&P 500 Index(.SPX.US)$, which has achieved a 24% gain. However, analysts indicate that the previously cool sent...

GAME_DAY

Jun 12, 2023 16:40

TOP WATCH AH + 6/13 ⚡️⚡️

$Auddia(AUUD.US)$ $Charles River(CRL.US)$ $Devon Energy(DVN.US)$ $Eastside Distilling(EAST.US)$ $Finch Therapeutics(FNCH.US)$ $Forza X1(FRZA.US)$ $iBio Inc(IBIO.US)$ $Disc Medicine(IRON.US)$ $Leju Holdings(LEJU.US)$ $Lumen Technologies(LUMN.US)$ $MediaCo(MDIA.US)$ $The OLB Group(OLB.US)$ $Oracle(ORCL.US)$ $Rockwell Medical(RMTI.US)$ $Target(TGT.US)$

Analysts Notebook

Jun 12, 2023 07:30

ColumnsUS Top Rating Updates on 6/12: AZO, ORCL, BILL, KMX and More

$ArcBest(ARCB.US)$ initiated at buy by Jefferies, announced target price at $110.00.
$Saia(SAIA.US)$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone(AZO.US)$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle(ORCL.US)$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings(BILL.US)$ was downg...

ilovemoney29

Jan 24, 2023 20:27

$Disc Medicine(IRON.US)$ no attention very recent rs and it flies

No comment yet